Dermatology News

The FDA has approved 320 mg pre-filled syringes and autoinjectors of Bimzelx for the treatment of active psoriatic arthritis with coexisting moderate-to-severe plaque psoriasis, according to a press release from UCB.

A new study confirmed previous findings that acne products containing benzoyl peroxide have high levels of cancer-causing benzene which are not stabilized by encapsulation techniques even at room temperature.

Treatment with apremilast led to improved clinical and patient-reported outcomes in early oligoarticular psoriatic arthritis at 16 weeks, according to data published in Annals of the Rheumatic Diseases.

The first over-the-counter monograph order request tier 1 application for bemotrizinol, an active sunscreen ingredient, has been submitted to the FDA, dsm-firmenich announced in a press release.

Skin cancer is the most prevalent cancer in the United States, with an estimated 97,610 new cases of invasive melanoma, 89,070 cases of in situ melanoma and about 7,990 deaths from the disease in 2023.

SAN DIEGO — GLP-1 agonists and other drugs that have recently made headlines for their weight loss applications will be useful in helping patients meet goals in psoriatic arthritis and other rheumatic diseases, according to a speaker here.

SAN DIEGO — New imaging technologies, and improved use of the ones currently available, may move rheumatology closer to precision medicine in inflammatory arthritis, according to a speaker at the 2024 Congress of Clinical Rheumatology West.

A previously healthy, 14-year-old girl is admitted to the hospital after complaints of painful swelling of her lower lip, with periodic spotty, blood-tinged drainage from several discrete areas with overlying dark scabs.

Smoking, substance use disorder and taking gabapentinoids or antidepressants predict long-term opioid use among patients with axial spondyloarthritis and psoriatic arthritis, according to data published in Rheumatology.

Use of elderberry as an herbal supplement preceded disease exacerbation in 62% of patients with dermatomyositis, and in 50% of those with cutaneous lupus erythematosus, according to data published in ACR Open Rheumatology.